Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
Hasaya Dokduang, Puangrat Yongvanit, Nisana Namwat, et al.
Oncology Reports (2016) Vol. 35, Iss. 4, pp. 2065-2072
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Lipid metabolism reprogramming and its potential targets in cancer
Chunming Cheng, Feng Geng, Xiang Cheng, et al.
Cancer Communications (2018) Vol. 38, Iss. 1, pp. 1-14
Open Access | Times Cited: 657
Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops (Humulus lupulus L.)
Chuanhao Jiang, Taoli Sun, Daxiong Xiang, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 193
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy
Xiang Cheng, Jianying Li, Deliang Guo
Current Topics in Medicinal Chemistry (2018) Vol. 18, Iss. 6, pp. 484-493
Open Access | Times Cited: 114
Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
Chitra Rajagopal, Manendra Babu Lankadasari, Jesil Mathew Aranjani, et al.
Pharmacological Research (2018) Vol. 130, pp. 273-291
Closed Access | Times Cited: 105
Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets
Vancha Harish, Effi Haque, Magdalena Śmiech, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4478-4478
Open Access | Times Cited: 59
Xanthohumol from Hop: Hope for cancer prevention and treatment
Sosmitha Girisa, Queen Saikia, Devivasha Bordoloi, et al.
IUBMB Life (2021) Vol. 73, Iss. 8, pp. 1016-1044
Open Access | Times Cited: 59
Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones
Violetta Krajka‐Kuźniak, Marta Belka, Katarzyna Papierska
Cancers (2024) Vol. 16, Iss. 6, pp. 1092-1092
Open Access | Times Cited: 11
Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones
Radka Michalková, Ladislav Mirossay, Maria Gazdova, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2730-2730
Open Access | Times Cited: 46
Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment
Shadi Vesaghhamedani, Farnoosh Ebrahimzadeh, Elnaz Najafi, et al.
Progress in Biophysics and Molecular Biology (2022) Vol. 172, pp. 3-14
Closed Access | Times Cited: 28
Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma
Minxiao Chen, Chenchen Qian, Bo Jin, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 16
Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants
Hamed Amani, Marjan Ajami, Solmaz Nasseri Maleki, et al.
Biochimie (2017) Vol. 142, pp. 63-79
Closed Access | Times Cited: 54
Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
Md. Abdul Aziz, Md Shahid Sarwar, Tahmina Akter, et al.
Life Sciences (2021) Vol. 268, pp. 118999-118999
Closed Access | Times Cited: 36
Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells
Adrianna Sławińska-Brych, Barbara Zdzisińska, Magdalena Dmoszyńska‐Graniczka, et al.
Toxicology (2016) Vol. 357-358, pp. 65-73
Closed Access | Times Cited: 45
Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines
Isabelle E. Logan, Cristobal L. Miranda, Malcolm B. Lowry, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1203-1203
Open Access | Times Cited: 42
Prenylated flavonoids in foods and their applications on cancer prevention
Lingrong Wen, Ting Zhou, Yueming Jiang, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 62, Iss. 18, pp. 5067-5080
Closed Access | Times Cited: 31
Xanthohumol induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI3K/Akt/mTOR-kinase in human gastric cancer cells
Dongli Guo, Zhang Bao-gui, Shiqi Liu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 1300-1306
Closed Access | Times Cited: 31
Xanthohumol protects against Azoxymethane‐induced colorectal cancer in Sprague‐Dawley rats
Hualin Liu, Lei Zhang, Guanghua Li, et al.
Environmental Toxicology (2019) Vol. 35, Iss. 2, pp. 136-144
Closed Access | Times Cited: 22
STAT3 Inhibitors in Cancer: A Comprehensive Update
Uddalak Bharadwaj, Moses M. Kasembeli, David J. Tweardy
Cancer drug discovery and develogment/Cancer drug discovery and development (2016), pp. 95-161
Closed Access | Times Cited: 19
Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis
Wassana Jamnongkan, Malinee Thanee, Puangrat Yongvanit, et al.
PeerJ (2018) Vol. 6, pp. e4281-e4281
Open Access | Times Cited: 15
Xanthohumol and Structurally Related Prenylflavonoids for Cancer Chemoprevention and Control
Jan F. Stevens
Springer eBooks (2020), pp. 319-350
Closed Access | Times Cited: 13
Xanthohumol inhibits proliferation of laryngeal squamous cell carcinoma
Yan Li, Kai Wang, Shankai Yin, et al.
Oncology Letters (2016) Vol. 12, Iss. 6, pp. 5289-5294
Open Access | Times Cited: 11
Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential
Hardeep Singh Tuli, Vaishali Aggarwal, Gaurav Parashar, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 3, pp. 418-432
Closed Access | Times Cited: 10
Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α
Saini Wang, Anil Yadav, Jin‐Yi Han, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6353-6353
Open Access | Times Cited: 7
Xanthohumol-Enriched Beer Does Not Exert Antitumorigenic Effects on HeLa Cell Line In Vivo
Anna Júlia Éliás, Lajos Balogh, Tomáš Brányik, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1070-1070
Open Access | Times Cited: 3
Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy
Suyanee Thongchot, Malinee Thanee, Watcharin Loilome, et al.
Journal of Traditional and Complementary Medicine (2019) Vol. 10, Iss. 3, pp. 230-235
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top